Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection.
PubMed Full text in PMC Similar studies
Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection. [2]
Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection. [1]
Therapeutic targeting of Chronic Kidney Disease-associated DAMPs differentially contributing to vascular pathology.
Therapeutic targeting of Chronic Kidney Disease-associated DAMPs differentially contributing to vascular pathology. [atherosclerosis AAN+Paquinimod aortas]
Therapeutic targeting of Chronic Kidney Disease-associated DAMPs differentially contributing to vascular pathology. [atherosclerosis AAN+sTLR2 aortas]
Effects of TREM-1 pharmacological blockade within aortas of apoE KO mice
Analyze with GEO2R
RT² Profiler™ PCR Array Mouse Atherosclerosis
PDF-exposed mice + S.epidermidis peritonitis
Non infected PDF-exposed mice (i.p. catheter fitter, daily PDF administration)
Control + S.epidermidis peritonitis
Non-infected Control mice
S.epidermidis-injected mice with Paquinimod treatment
S.epidermidis-injected mice
Control mice sample
AAN mice with Paquinimod treatment
Aristolochic Acid -induced Nephropathic (ANN) mice.
Control mice
AAN mice with soluble TLR2 treatment
Aristolochic Acid -induced Nephropathic (ANN) mice
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on